高级检索
当前位置: 首页 > 详情页

Acute Treatment with Nicotinamide Riboside Chloride Reduces Hippocampal Damage and Preserves the Cognitive Function of Mice with Ischemic Injury

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Neurol,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China [2]Xinxiang Med Univ, Affiliated Hosp 1, Henan Key Lab Neurorestoratol, Xinxiang 453100, Henan, Peoples R China [3]1 Peoples Hosp Jingzhou City, Jingzhou 434000, Peoples R China [4]Yangtze Univ, Hosp 1, Jingzhou 434000, Peoples R China [5]Huazhong Univ Sci & Technol, Clin Coll 2, Tongji Med Coll, Wuhan 430030, Peoples R China
出处:
ISSN:

关键词: Nicotinamide riboside Hippocampus Ischemia Vascular cognition

摘要:
Nicotinamide adenine dinucleotide (NAD) is a critical cosubstrate for enzymes involved in supplying energy to the brain. Nicotinamide riboside (NR), an NAD(+) precursor, emerges as a neuroprotective factor after chronic brain insults. However, researchers have not determined whether it improves cognition after acute ischemia. In the present study, mice with middle cerebral artery occlusion were treated with NR chloride (NRC, 300 mg/kg, IP., 20 min after reperfusion). The results of the Morris water maze test revealed better recovery of learning and memory function in the NRC-treated group. Acute NRC treatment decreased hippocampal infarct volume, reduced neuronal loss and apoptosis in the hippocampus. Western blot and high-performance liquid chromatography assays of hippocampal tissues revealed that the activation of Sirtin-1 and adenosine 5 ' monophosphate-activated protein kinase was increased, the NAD content was elevated, and the production of adenosine triphosphate was strengthened by NRC. Collectively, acute NRC treatment increased the energy supply, reduced the neuronal loss and apoptosis, protected the hippocampus and ultimately promoted the recovery of cognitive function after brain ischemia.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 生化与分子生物学 4 区 神经科学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 生化与分子生物学 3 区 神经科学
JCR分区:
出版当年[2020]版:
Q2 NEUROSCIENCES Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2024]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 NEUROSCIENCES

影响因子: 最新[2024版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Neurol,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China [2]Xinxiang Med Univ, Affiliated Hosp 1, Henan Key Lab Neurorestoratol, Xinxiang 453100, Henan, Peoples R China [3]1 Peoples Hosp Jingzhou City, Jingzhou 434000, Peoples R China [4]Yangtze Univ, Hosp 1, Jingzhou 434000, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)